학술논문

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Document Type
Article
Source
In The Lancet Oncology May 2020 21(5):671-684
Subject
Primary Research
Articles
Language
ISSN
1470-2045